Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer

Journal of Clinical Oncology

Volumn 32, Issue 30, 2014, Pages 3400-3405

  Sudo, Kazuki ^a   Xiao, Lianchun ^a   Wadhwa, Roopma ^a   Shiozaki, Hironori ^a   Elimova, Elena ^a   Taketa, Takashi ^a   Blum, Mariela A ^a   Lee, Jeffrey H ^a   Bhutani, Manoop S ^a   Weston, Brian ^a   Ross, William A ^a   Komaki, Ritsuko ^a   Rice, David C ^a   Swisher, Stephen G ^a   Hofstetter, Wayne L ^a   Maru, Dipen M ^a   Skinner, Heath D ^a   Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHEMORADIOTHERAPY; COHORT ANALYSIS; DISTANT METASTASIS; DRUG TREATMENT FAILURE; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTENSIVE CARE UNIT; LOW LEVEL LASER THERAPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PROSPECTIVE STUDY; PROTON THERAPY; RADIATION DOSE; SALVAGE THERAPY; TREATMENT RESPONSE; TUMOR VOLUME; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SALVAGE THERAPY;

EID: 84908425491     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.7156     Document Type: Article

References (19)

1. Sudo K, Taketa T, Correa AM, et al: Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31:4306-4310, 2013
2. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011
3. van Hagen P, Hulshof MC, van Lanschot JJ, et al: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084, 2012
4. Ajani JA, Barthel JS, Bentrem DJ, et al: Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9:830-887, 2011
5. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01) - Radiation Therapy Oncology Group. JAMA 281:1623-1627, 1999
6. Welsh J, Settle SH, Amini A, et al: Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118:2632-2640, 2012
7. Suzuki A, Xiao L, Taketa T, et al: Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24:2854-2859, 2013
8. Amini A, Xiao L, Allen PK, et al: Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83:e231-e239, 2012
9. Oppedijk V, van der Gaast A, van Lanschot JJ, et al: Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol 32:385-391, 2014
10. Bekkar S, Gronnier C, Messager M, et al: The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. Ann Thorac Surg 97:303-310, 2014
11. Mariette C, Robb WB, Piessen G: Reply to letter: "The role of surgery for patients with a complete clinical response after chemoradiation for esophageal cancer." Ann Surg [epub ahead of print on March 25, 2014]
12. Davies AR, Sandhu H, Pillai A, et al: Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer. Br J Surg 101: 511-517, 2014
13. Amini A, Ajani J, Komaki R, et al: Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21:306-314, 2013
14. Edge S, Byrd DR, Comptin CC, et al: (eds): AJCC Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002, pp 93-94
15. Ajani JA, Xiao L, Roth JA, et al: A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24:2844-2849, 2013
16. National Comprehensive Cancer Network: NCCN guidelines, version 2.2013. Washington, PA, National Comprehensive Cancer Network, 2013. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp
17. Cheedella NK, Suzuki A, Xiao L, et al: Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: Analysis in a large cohort. Ann Oncol 24: 1262-1266, 2013
18. Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167-1174, 2002
19. Herskovic A, Martz K, al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992